NCT01728324View on ClinicalTrials.gov

Phase 3 Study of BI 207127 in Combination With Faldaprevir and Ribavirin for Treatment of Patients With Hepatitis C Infection, Including Patients Who Are Not Eligible to Receive Peginterferon: HCVerso2

PHASE3CompletedINTERVENTIONAL
Enrollment

496

Participants

Timeline

Start Date

November 30, 2012

Primary Completion Date

February 28, 2014

Study Completion Date

January 31, 2015

Conditions
Hepatitis C, Chronic
Interventions
DRUG

BI 207127-placebo: 8-week treatment

8 weeks of placebo treatment

DRUG

Ribavirin: 24-week treatment

24 weeks of active treatment

DRUG

BI 207127: 24-week treatment

24 weeks of active treatment

DRUG

Faldaprevir: 24-week treatment

24 weeks of active treatment

DRUG

Faldaprevir: 24-week treatment

24 weeks of active treatment

DRUG

Ribavirin-placebo: 8-week treatment

8 weeks of placebo treatment

DRUG

BI 207127: 24-week treatment

24 weeks of active treatment

DRUG

Faldaprevir-placebo: 8-week treatment

8 weeks of placebo treatment

DRUG

Faldaprevir: 16-week treatment

16 weeks of active treatment

DRUG

Ribavirin: 16-week treatment

16 weeks of active treatment

DRUG

RBV: 24-week treatment

24 weeks of active treatment

DRUG

BI 207127: 16-week treatment

16 weeks of active treatment

Trial Locations (109)

Unknown

1241.36.00016 Boehringer Ingelheim Investigational Site, North Little Rock

1241.36.00020 Boehringer Ingelheim Investigational Site, Anaheim

1241.36.00005 Boehringer Ingelheim Investigational Site, Bakersfield

1241.36.00009 Boehringer Ingelheim Investigational Site, La Jolla

1241.36.00007 Boehringer Ingelheim Investigational Site, Los Angeles

1241.36.00013 Boehringer Ingelheim Investigational Site, Oceanside

1241.36.00019 Boehringer Ingelheim Investigational Site, San Diego

1241.36.00034 Boehringer Ingelheim Investigational Site, San Francisco

1241.36.00022 Boehringer Ingelheim Investigational Site, Bradenton

1241.36.00004 Boehringer Ingelheim Investigational Site, DeLand

1241.36.00006 Boehringer Ingelheim Investigational Site, Fort Lauderdale

1241.36.00003 Boehringer Ingelheim Investigational Site, Gainesville

1241.36.00010 Boehringer Ingelheim Investigational Site, Orlando

1241.36.00024 Boehringer Ingelheim Investigational Site, Palm Harbor

1241.36.00030 Boehringer Ingelheim Investigational Site, Zephyrhills

1241.36.00027 Boehringer Ingelheim Investigational Site, Atlanta

1241.36.00033 Boehringer Ingelheim Investigational Site, Chicago

1241.36.00035 Boehringer Ingelheim Investigational Site, Springfield

1241.36.00001 Boehringer Ingelheim Investigational Site, Valparaiso

1241.36.00017 Boehringer Ingelheim Investigational Site, Baton Rouge

1241.36.00018 Boehringer Ingelheim Investigational Site, Tupelo

1241.36.00043 Boehringer Ingelheim Investigational Site, Kansas City

1241.36.00032 Boehringer Ingelheim Investigational Site, Hillsborough

1241.36.00002 Boehringer Ingelheim Investigational Site, Arlington

1241.36.00039 Boehringer Ingelheim Investigational Site, Austin

1241.36.00031 Boehringer Ingelheim Investigational Site, Dallas

1241.36.00008 Boehringer Ingelheim Investigational Site, Murray

1241.36.00026 Boehringer Ingelheim Investigational Site, Charlottesville

1241.36.00044 Boehringer Ingelheim Investigational Site, Newport News

1241.36.00015 Boehringer Ingelheim Investigational Site, Norfolk

1241.36.00029 Boehringer Ingelheim Investigational Site, Richmond

1241.36.61005 Boehringer Ingelheim Investigational Site, Camperdown

1241.36.61010 Boehringer Ingelheim Investigational Site, Kogarah

1241.36.61009 Boehringer Ingelheim Investigational Site, New Lambton

1241.36.61007 Boehringer Ingelheim Investigational Site, Randwick

1241.36.61002 Boehringer Ingelheim Investigational Site, Herston

1241.36.61004 Boehringer Ingelheim Investigational Site, Clayton

1241.36.61001 Boehringer Ingelheim Investigational Site, Darlinghurst

1241.36.61008 Boehringer Ingelheim Investigational Site, Heidelberg

1241.36.61006 Boehringer Ingelheim Investigational Site, Melbourne

1241.36.32006 Boehringer Ingelheim Investigational Site, Antwerp

1241.36.32001 Boehringer Ingelheim Investigational Site, Brussels

1241.36.32004 Boehringer Ingelheim Investigational Site, Edegem

1241.36.32005 Boehringer Ingelheim Investigational Site, Ghent

1241.36.32002 Boehringer Ingelheim Investigational Site, Leuven

1241.36.32003 Boehringer Ingelheim Investigational Site, Liège

1241.36.32007 Boehringer Ingelheim Investigational Site, Roeselare

1241.36.01005 Boehringer Ingelheim Investigational Site, Calgary

1241.36.01006 Boehringer Ingelheim Investigational Site, Vancouver

1241.36.01002 Boehringer Ingelheim Investigational Site, Winnipeg

1241.36.01003 Boehringer Ingelheim Investigational Site, London

1241.36.01001 Boehringer Ingelheim Investigational Site, Ottawa

1241.36.01004 Boehringer Ingelheim Investigational Site, Toronto

1241.36.01007 Boehringer Ingelheim Investigational Site, Toronto

1241.36.33001 Boehringer Ingelheim Investigational Site, Clichy

1241.36.33004 Boehringer Ingelheim Investigational Site, Créteil

1241.36.33002 Boehringer Ingelheim Investigational Site, Grenoble

1241.36.33003 Boehringer Ingelheim Investigational Site, Paris

1241.36.33008 Boehringer Ingelheim Investigational Site, Paris

1241.36.33006 Boehringer Ingelheim Investigational Site, Saint-Laurent-du-Var

1241.36.33005 Boehringer Ingelheim Investigational Site, Toulouse

1241.36.33007 Boehringer Ingelheim Investigational Site, Villejuif

1241.36.49011 Boehringer Ingelheim Investigational Site, Aachen

1241.36.49001 Boehringer Ingelheim Investigational Site, Berlin

1241.36.49012 Boehringer Ingelheim Investigational Site, Dortmund

1241.36.49004 Boehringer Ingelheim Investigational Site, Düsseldorf

1241.36.49008 Boehringer Ingelheim Investigational Site, Erlangen

1241.36.49009 Boehringer Ingelheim Investigational Site, Esslingen am Neckar

1241.36.49014 Boehringer Ingelheim Investigational Site, Freiburg im Breisgau

1241.36.49002 Boehringer Ingelheim Investigational Site, Hamburg

1241.36.49007 Boehringer Ingelheim Investigational Site, Mainz

1241.36.49013 Boehringer Ingelheim Investigational Site, Tübingen

1241.36.30001 Boehringer Ingelheim Investigational Site, Athens

1241.36.30002 Boehringer Ingelheim Investigational Site, Athens

1241.36.30003 Boehringer Ingelheim Investigational Site, Pátrai

1241.36.30004 Boehringer Ingelheim Investigational Site, Rhodes

1241.36.39025 Boehringer Ingelheim Investigational Site, Antella (fi)

1241.36.39023 Boehringer Ingelheim Investigational Site, Bisceglie (bat)

1241.36.39021 Boehringer Ingelheim Investigational Site, Bologna

1241.36.39022 Boehringer Ingelheim Investigational Site, Milan

1241.36.39020 Boehringer Ingelheim Investigational Site, Palermo

1241.36.39026 Boehringer Ingelheim Investigational Site, Pavia

1241.36.39028 Boehringer Ingelheim Investigational Site, Pescara

1241.36.39029 Boehringer Ingelheim Investigational Site, Roma

1241.36.39024 Boehringer Ingelheim Investigational Site, San Giovanni Rotondo (fg)

1241.36.64001 Boehringer Ingelheim Investigational Site, Auckland NZ

1241.36.64002 Boehringer Ingelheim Investigational Site, Hamilton

1241.36.35103 Boehringer Ingelheim Investigational Site, Barreiro

1241.36.35104 Boehringer Ingelheim Investigational Site, Coimbra

1241.36.35101 Boehringer Ingelheim Investigational Site, Lisbon

1241.36.34006 Boehringer Ingelheim Investigational Site, Badalona (Barcelona)

1241.36.34002 Boehringer Ingelheim Investigational Site, Barcelona

1241.36.34004 Boehringer Ingelheim Investigational Site, Barcelona

1241.36.34001 Boehringer Ingelheim Investigational Site, L'Hospitalet Llobregat (bcn)

1241.36.34005 Boehringer Ingelheim Investigational Site, Madrid

1241.36.34008 Boehringer Ingelheim Investigational Site, Málaga

1241.36.34003 Boehringer Ingelheim Investigational Site, Seville

1241.36.34007 Boehringer Ingelheim Investigational Site, Vigo (Pontevedra)

1241.36.44003 Boehringer Ingelheim Investigational Site, Birmingham

1241.36.44006 Boehringer Ingelheim Investigational Site, Edinburgh

1241.36.44011 Boehringer Ingelheim Investigational Site, Hull

1241.36.44013 Boehringer Ingelheim Investigational Site, Leeds

1241.36.44008 Boehringer Ingelheim Investigational Site, Leicester

1241.36.44001 Boehringer Ingelheim Investigational Site, London

1241.36.44005 Boehringer Ingelheim Investigational Site, London

1241.36.44007 Boehringer Ingelheim Investigational Site, Manchester

1241.36.44010 Boehringer Ingelheim Investigational Site, Newcastle upon Tyne

1241.36.44002 Boehringer Ingelheim Investigational Site, Oxford

1241.36.44004 Boehringer Ingelheim Investigational Site, Plymouth

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY